Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants
NCT02367885
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
99
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza Infection
Interventions
DRUG:
TAK-850 0.5 mL injection
DRUG:
TAK-850 0.25 mL injection
Sponsor
Takeda